-+ 0.00%
-+ 0.00%
-+ 0.00%

SPYRE THERAPEUTICS: SPY003 WELL TOLERATED AT ALL DOSE LEVELS, FAVORABLE SAFETY PROFILE CONSISTENT WITH ANTI-IL-23 CLASS

Reuters·11/04/2025 21:01:01

Please log in to view news